ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

MEIP MEI Pharma Inc

3,06
0,00 (0,00%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
MEI Pharma Inc MEIP NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 3,06 06:00:02
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,13 3,06 3,21 3,06 3,06
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
11.4.202414:02BWMEI Pharma Board of Directors Aligns on Strategy to Advance..
11.4.202414:00BWMEI Pharma Reports Initial Data from Clinical Study..
10.4.202414:00BWMEI Pharma to Present at the Stifel 2024 Virtual Targeted..
26.3.202413:00BWMEI Pharma Reports Update from Clinical Study Evaluating..
29.2.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
21.2.202422:00EDGAR2Form 8-K - Current report
20.2.202423:33EDGAR2Form S-3 - Registration statement under Securities Act of..
13.2.202423:05EDGAR2Form 8-K - Current report
13.2.202423:05BWMEI Pharma Reports Second Quarter Fiscal Year 2024 Results..
17.1.202422:00EDGAR2Form 8-K - Current report
16.1.202423:00BWMEI Pharma to Present Design of Ongoing Clinical Study..
26.12.202323:00EDGAR2Form 8-K - Current report
22.12.202322:00EDGAR2Form 8-K - Current report
21.12.202303:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202303:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202322:00EDGAR2Form 8-K - Current report
11.12.202322:00EDGAR2Form 8-K - Current report
11.12.202318:00BWMEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor..
15.11.202302:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
09.11.202322:06EDGAR2Form 8-K - Current report
09.11.202322:05BWMEI Pharma Reports First Quarter Fiscal Year 2024 Results..
09.11.202322:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.11.202323:03EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08.11.202323:02EDGAR2Form DEF 14A - Other definitive proxy statements
08.11.202314:00BWMEI Pharma to Present at the Stifel 2023 Healthcare..
06.11.202322:57BWMEI Pharma Declares Special Cash Dividend of $1.75 Per Share..
03.11.202323:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
02.11.202314:00BWMEI Pharma Announces Acceptance of Abstract for Presentation..
01.11.202322:20EDGAR2Form SC 13D/A - General statement of acquisition of..
01.11.202322:15EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
01.11.202321:54EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01.11.202321:01EDGAR2Form 8-K - Current report
01.11.202314:00BWMEI Pharma Enters into Agreement with Anson Funds and Cable..
27.10.202322:05EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
25.10.202301:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.10.202301:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.10.202323:00EDGAR2Form SC 13D/A - General statement of acquisition of..
17.10.202323:33BWMEI Pharma Recommends Stockholders Not to Consent
17.10.202323:28EDGAR2Form DEFC14A - Definitive proxy statement, contested..
13.10.202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.10.202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.10.202323:00EDGAR2Form SC 13D/A - General statement of acquisition of..
13.10.202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.10.202301:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.10.202301:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.10.202301:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.10.202301:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.10.202323:25EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
10.10.202321:00EDGAR2Form DFAN14A - Additional definitive proxy soliciting..
10.10.202316:33EDGAR2Form DEFC14A - Definitive proxy statement, contested..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock